Menopause changes more than your periods. It shifts where your body stores fat — toward the abdomen — and chips away at muscle, alongside broader metabolic changes. That overlaps with exactly what a GLP-1 is working on, which is why hormone therapy and GLP-1s often come up in the same conversation. They're different tools, though, and it helps to be clear about which does what.
What HRT is (for women)
Menopausal hormone therapy (MHT, often just "HRT") replaces the estrogen that falls at menopause — usually paired with a progestogen if you still have a uterus, to protect the uterine lining. It comes as pills, skin patches, gels, and sprays. Its main job is treating menopausal symptoms, not weight.
Who benefits
HRT is generally considered for:
- Moderate-to-severe menopausal symptoms — hot flashes and night sweats (vasomotor symptoms), and genitourinary symptoms like vaginal dryness.
- Bone protection — it helps prevent the accelerated bone loss of menopause.
- The benefit–risk balance is most favorable when started near menopause (roughly under age 60 or within 10 years of your last period).
It's an individualized decision: the risks (including breast cancer and blood clots) depend on the type of hormones, how they're delivered, timing, and your personal and family history. This is a conversation with your clinician, not a one-size-fits-all.
The menopause–weight connection
After menopause, women tend to gain fat — especially visceral (deep abdominal) fat — and lose some muscle, with a less favorable metabolic profile. This is often when midlife women consider a GLP-1 for weight.
Where HRT and GLP-1s intersect
- HRT is associated with less visceral fat — but it is not a weight-loss treatment. In observational data, current HRT users had lower visceral fat and BMI than never-users, with the benefit fading after stopping — but HRT did not preserve muscle, and controlled data (e.g., in surgical menopause) found no body-composition benefit from HRT. So HRT can nudge fat distribution, but it won't do a GLP-1's job.
- A GLP-1 targets weight and appetite directly. Some women, under medical care, use both — a GLP-1 for weight, HRT for menopausal symptoms. They address different problems that happen to coincide in midlife.
- Protect your muscle. Because GLP-1 weight loss can cost lean mass and menopause already erodes muscle, protein and resistance training matter even more here (see the movement and strength guides).
- One GLP-1 caution to know: tirzepatide can reduce the absorption and effectiveness of oral contraceptives (per its label). That's contraception, not HRT — but if it's relevant to you, raise it with your clinician.
Bottom line
HRT and GLP-1 medications solve different problems that overlap in midlife, and neither replaces the other. If both are on the table, coordinate them with your clinician — the combination is individualized and the direct combination evidence is still limited. For the men's side and a broader view, see the companion pages on HRT for men and the HRT + GLP-1 overview.
This is general education, not medical advice. Hormone therapy has real benefits and risks that depend on your individual history — decide with your clinician.